Bioporto A/S logo

BIOPOR - Bioporto A/S News Story

DKK3.97 0.0  0.0%

Last Trade - 12/05/21

Small Cap
Market Cap £123.0m
Enterprise Value £114.2m
Revenue £2.85m
Position in Universe 846th / 1832

Corrected Financial Calendar 2019

Tue 8th January, 2019 11:13am
Corrected Financial Calendar 2019

January 8, 2019

Announcement no. 1


Corrected Financial Calendar 2019


January 25, 2019
Quiet Period prior to the Annual Report begins (4 weeks)
February 1, 2019Deadline for shareholder proposals - Annual General Meeting
February 22, 2019Annual Report 2018 & Investor Meeting
March 18, 2019Annual General Meeting
April 25, 2019Quiet Period prior to the Interim Report begins (2 weeks)
May 9, 2019Interim Report – 3 months 2019 & Investor Meeting
August 1, 2019Quiet Period prior to the Interim Report begins (2 weeks)
August 15, 2019Interim Report – 6 months 2019 & Investor Meeting
October 24, 2019Quiet Period prior to the Interim Report begins (2 weeks)
November 7, 2019Interim Report – 9 months 2019 & Investor Meeting


For further information, please contact:
Gry Husby Larsen, General Counsel
Telephone +45 4529 0000, e-mail


About BioPorto
BioPorto is an in-vitro diagnostics company that provides healthcare professionals in clinical and research settings a range of diagnostic tests and antibodies. BioPorto has its headquarters in Hellerup, Denmark and is listed on the NASDAQ Copenhagen stock exchange.



© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.